Cue Biopharma paid its 5 named executives $5.2M in total in FY2025 (Dec). CEO Usman Azam was paid $1.2M of that.
Pay$100 in the stock at the end of FY24 → $28
Pay of each named executive
Daniel R. PasseriFormer Chief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Matteo LevisettiFormer Chief Medical Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
Usman AzamPresident and Chief Executive Officer
| FY2025 (Dec) |
1 year
Lucinda WarrenChief Financial and Business Officer
| FY2025 (Dec) |
1 year
Colin SandercockSVP, General Counsel and Secretary
| FY2025 (Dec) |
1 year
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.